Growth Metrics

Usana Health Sciences (USNA) Free Cash Flow (2016 - 2026)

Usana Health Sciences has reported Free Cash Flow over the past 16 years, most recently at $7.1 million for Q2 2026.

  • Quarterly Free Cash Flow fell 53.96% to $7.1 million in Q2 2026 from the year-ago period, while the trailing twelve-month figure was $189000.0 through Apr 2026, down 99.68% year-over-year, with the annual reading at $8.5 million for FY2026, 86.01% down from the prior year.
  • Free Cash Flow was $7.1 million for Q2 2026 at Usana Health Sciences, up from -$6.2 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at $46.3 million in Q4 2022 and troughed at -$12.9 million in Q3 2025.
  • The 5-year median for Free Cash Flow is $14.2 million (2022), against an average of $14.3 million.
  • Year-over-year, Free Cash Flow soared 453.66% in 2025 and then crashed 205.84% in 2026.
  • A 5-year view of Free Cash Flow shows it stood at $46.3 million in 2022, then tumbled by 72.12% to $12.9 million in 2023, then crashed by 54.74% to $5.8 million in 2024, then plummeted by 321.18% to -$12.9 million in 2025, then surged by 155.04% to $7.1 million in 2026.
  • Per Business Quant, the three most recent readings for USNA's Free Cash Flow are $7.1 million (Q2 2026), -$6.2 million (Q1 2026), and -$12.9 million (Q3 2025).